Lv31
222 积分 2021-10-28 加入
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2小时前
已关闭
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2小时前
已完结
Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch
2个月前
已完结
Discovery and Optimization of Novel Nonbile Acid FXR Agonists as Preclinical Candidates for the Treatment of Inflammatory Bowel Disease
2个月前
已完结
[Clinical practice guidelines for alpha-thalassemia]
2个月前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
3个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease
4个月前
已完结
Chinese innovative drug R&D trends in 2024
4个月前
已完结
An overview of the safety and efficacy of LX-9211 in treating neuropathic pain conditions
5个月前
已完结
皖公网安备34019202002308
